DiaMedica Therapeutics Inc.
US ˙ NasdaqCM ˙ CA25253X2077

SecurityDMAC / DiaMedica Therapeutics Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership1,856,187 shares
Latest Disclosed Value $ 12,566,385
BlackRock, Inc. reports 2.35% decrease in ownership of DMAC / DiaMedica Therapeutics Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 1,856,187 shares of DiaMedica Therapeutics Inc. (US:DMAC) valued at $12,566,386 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,900,899 shares of DiaMedica Therapeutics Inc.. This represents a change in shares of -2.35% during the quarter. The current value of the position is $10,840,132 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,856,187 -44,712 -2.35 12,566 -16.95 0.0000
2026-02-12 2025-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,900,899 222,760 13.27 15,131 31.25 0.0003
2025-11-12 2025-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,678,139 486,326 40.81 11,529 148.02 0.0002
2025-08-12 2025-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,191,813 1,085,463 1,020.65 4,648 1,053.35 0.0001
2025-05-02 2025-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 106,350 -1,530 -1.42 403 -31.11 0.0000
2025-02-07 2024-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 107,880 90 0.08 586 29.71 0.0000
2024-11-13 2024-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 107,790 2,487 2.36 452 45.48 0.0000
2024-08-13 2024-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 105,303 1,933 1.87 311 8.39 0.0000
2024-05-10 2024-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 103,370 -1,362 -1.30 286 -3.70 0.0000
2024-02-13 2023-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 104,732 3,007 2.96 297 13.36 0.0000
2023-11-13 2023-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 101,725 29,810 41.45 262 -15.48 0.0000
2023-08-11 2023-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 71,915 245 0.34 311 184.40 0.0000
2023-05-12 2023-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 71,670 1,733 2.48 110 -0.91 0.0000
2023-02-13 2022-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 69,937 1,067 1.55 111 29.41 0.0000
2022-11-14 2022-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 68,870 2,153 3.23 85 -37.04 0.0000
2022-08-12 2022-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 66,717 10,278 18.21 135 -4.26 0.0000
2022-05-12 2022-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 56,439 -2,133 -3.64 141 -35.62 0.0000
2022-02-10 2021-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 58,572 2,602 4.65 219 -2.67 0.0000
2021-11-09 2021-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 55,970 -5,289 -8.63 225 -17.58 0.0000
2021-08-11 2021-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 61,259 1,094 1.82 273 -50.45 0.0000
2021-05-07 2021-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 60,165 4,384 7.86 551 -2.65 0.0000
2021-02-05 2020-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 55,781 12,008 27.43 566 205.95 0.0000
2020-11-06 2020-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 43,773 -735 -1.65 185 -40.13 0.0000
2020-08-14 2020-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 44,508 6,135 15.99 309 186.11 0.0000
2020-05-01 2020-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 38,373 6,320 19.72 108 -30.77 0.0000
2020-02-13 2019-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 32,053 6,441 25.15 156 194.34 0.0000
2019-11-08 2019-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 25,612 -1,463 -5.40 53 -60.45 0.0000
2019-08-22 2019-06-30 13F/A-1 DIAMEDICA THERAPEUTICS COM NEW 25253X207 27,075 16,651 159.74 134 185.11 0.0000
2019-08-13 2019-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 27,075 16,651 134
2019-05-09 2019-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 10,424 10,424 47 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.